title: Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
abstract: OBJECTIVE
  The dynorphin/kappa opioid receptor (KOR) system has been implicated as a critical component of the stress response. Stress-induced activation of dynorphin-KOR is well known to produce analgesia, and more recently, it has been implicated as a mediator of stress-induced responses including anxiety, depression, and reinstatement of drug seeking.
  
  
  OBJECTIVE
  Drugs selectively targeting specific KOR signaling pathways may prove potentially useful as therapeutic treatments for mood and addiction disorders.
  
  
  RESULTS
  KOR is a member of the seven transmembrane spanning (7TM) G-protein coupled receptor (GPCR) superfamily. KOR activation of pertussis toxin-sensitive G proteins leads to Galphai/o inhibition of adenylyl cyclase production of cAMP and releases Gbetagamma, which modulates the conductances of Ca(+2) and K(+) channels. In addition, KOR agonists activate kinase cascades including G-protein coupled Receptor Kinases (GRK) and members of the mitogen-activated protein kinase (MAPK) family: ERK1/2, p38 and JNK. Recent pharmacological data suggests that GPCRs exist as dynamic, multi-conformational protein complexes that can be directed by specific ligands towards distinct signaling pathways. Ligand-induced conformations of KOR that evoke beta-arrestin-dependent p38 MAPK activation result in aversion; whereas ligand-induced conformations that activate JNK without activating arrestin produce long-lasting inactivation of KOR signaling.
  
  
  CONCLUSIONS
  In this review, we discuss the current status of KOR signal transduction research and the data that support two novel hypotheses: (1) KOR selective partial agonists that do not efficiently activate p38 MAPK may be useful analgesics without producing the dysphoric or hallucinogenic effects of selective, highly efficacious KOR agonists and (2) KOR antagonists that do not activate JNK may be effective short-acting drugs that may promote stress-resilience.
authors.affiliation: Department of Pharmacology, University of Washington, Seattle, WA 98195, USA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Bruchas
authors.forename: Charles
authors.initials: C
authors.lastname: Chavkin
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004399:Dynorphins / Q000502:physiology*; D004789:Enzyme Activation; D054768:G-Protein-Coupled Receptor Kinases / Q000378:metabolism; D006801:Humans; D008024:Ligands; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D015398:Signal Transduction; D013312:Stress, Physiological
chemical_list: D008024:Ligands; D017473:Receptors, Opioid, kappa; D004399:Dynorphins; D000242:Cyclic AMP; D054768:G-Protein-Coupled Receptor Kinases; D020928:Mitogen-Activated Protein Kinases; D000262:Adenylyl Cyclases
references.citation: Biochem Biophys Res Commun. 1984 Jun 15;121(2):641-8
references.pmid: 6145418
references.citation: J Biol Chem. 2004 Jan 16;279(3):1810-8
references.pmid: 14597630
references.citation: Psychopharmacology (Berl). 2005 Nov;183(1):118-26
references.pmid: 16184376
references.citation: J Pharmacol Exp Ther. 2006 Feb;316(2):933-9
references.pmid: 16249373
references.citation: J Pharmacol Exp Ther. 2004 Mar;308(3):1197-203
references.pmid: 14718611
references.citation: Mol Pharmacol. 2002 Jan;61(1):73-84
references.pmid: 11752208
references.citation: Br J Pharmacol. 1997 Feb;120(4 Suppl):106-20; discussion 103-5
references.pmid: 9142399
references.citation: Mol Pharmacol. 2003 Jan;63(1):9-18
references.pmid: 12488531
references.citation: Cell Mol Life Sci. 1999 Aug 15;55(10):1230-54
references.pmid: 10487205
references.citation: J Pharmacol Exp Ther. 2005 Jan;312(1):220-30
references.pmid: 15383632
references.citation: J Biol Chem. 1999 Apr 23;274(17):12087-94
references.pmid: 10207034
references.citation: Curr Opin Neurobiol. 2004 Jun;14(3):311-7
references.pmid: 15194111
references.citation: J Biol Chem. 1997 Jan 10;272(2):782-90
references.pmid: 8995364
references.citation: Traffic. 2008 Sep;9(9):1393-402
references.pmid: 18445122
references.citation: Curr Opin Genet Dev. 1994 Feb;4(1):77-81
references.pmid: 8193544
references.citation: Brain Res Dev Brain Res. 1993 Dec 17;76(2):189-96
references.pmid: 8149585
references.citation: J Physiol. 2003 May 1;548(Pt 3):765-75
references.pmid: 12651920
references.citation: Mol Pharmacol. 2006 Oct;70(4):1264-70
references.pmid: 16870886
references.citation: Science. 2000 Nov 24;290(5496):1574-7
references.pmid: 11090355
references.citation: Brain Res. 2010 Feb 16;1314:44-55
references.pmid: 19716811
references.citation: J Biol Chem. 2006 Jun 30;281(26):18081-9
references.pmid: 16648139
references.citation: Rev Neurosci. 1995 Jul-Sep;6(3):279-86
references.pmid: 8717638
references.citation: Nat Rev Neurosci. 2004 Mar;5(3):173-83
references.pmid: 14976517
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4344-51
references.pmid: 16537406
references.citation: Mol Pharmacol. 2005 Jun;67(6):2016-24
references.pmid: 15749995
references.citation: J Neurosci. 2008 Mar 19;28(12):3190-201
references.pmid: 18354022
references.citation: Nature. 1976 Jul 22;262(5566):313-4
references.pmid: 183126
references.citation: J Neurosci. 2006 Mar 29;26(13):3551-60
references.pmid: 16571763
references.citation: Nat Rev Immunol. 2006 Jul;6(7):532-40
references.pmid: 16799472
references.citation: J Biol Chem. 2007 Oct 12;282(41):29803-11
references.pmid: 17702750
references.citation: J Biol Chem. 1999 May 14;274(20):13978-84
references.pmid: 10318809
references.citation: J Pharmacol Exp Ther. 2003 May;305(2):531-40
references.pmid: 12606694
references.citation: Curr Opin Pharmacol. 2009 Feb;9(1):74-80
references.pmid: 19155191
references.citation: Science. 1998 Dec 18;282(5397):2272-5
references.pmid: 9856954
references.citation: DNA Cell Biol. 2000 Jan;19(1):19-27
references.pmid: 10668788
references.citation: J Pharmacol Exp Ther. 1989 Oct;251(1):21-6
references.pmid: 2552075
references.citation: J Neurochem. 2005 Sep;94(5):1457-70
references.pmid: 15992362
references.citation: Science. 2005 Apr 22;308(5721):512-7
references.pmid: 15845844
references.citation: Trends Pharmacol Sci. 2007 Aug;28(8):416-22
references.pmid: 17644195
references.citation: Psychopharmacology (Berl). 2008 Sep;200(1):59-70
references.pmid: 18575850
references.citation: J Neurosci. 2007 Mar 7;27(10):2570-81
references.pmid: 17344394
references.citation: J Neurosci. 2008 Jan 9;28(2):407-14
references.pmid: 18184783
references.citation: Neuropsychopharmacology. 2006 Jun;31(6):1241-8
references.pmid: 16123746
references.citation: Arch Int Pharmacodyn Ther. 1954 Sep 1;99(1):32-49
references.pmid: 13229418
references.citation: Trends Pharmacol Sci. 2003 Jul;24(7):346-54
references.pmid: 12871667
references.citation: J Neurochem. 2004 Apr;89(2):391-402
references.pmid: 15056283
references.citation: Mol Pharmacol. 2005 Apr;67(4):1229-36
references.pmid: 15635042
references.citation: Biochem Pharmacol. 1998 Aug 1;56(3):269-77
references.pmid: 9744561
references.citation: Pharmacol Rev. 2005 Jun;57(2):147-61
references.pmid: 15914464
references.citation: NIDA Res Monogr. 1990;105:34-9
references.pmid: 1652075
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11545-50
references.pmid: 16055563
references.citation: Trends Pharmacol Sci. 2007 Aug;28(8):407-15
references.pmid: 17629960
references.citation: Trends Neurosci. 2001 Aug;24(8):450-5
references.pmid: 11476884
references.citation: J Neurosci. 2007 Oct 24;27(43):11614-23
references.pmid: 17959804
references.citation: Life Sci. 1978 Aug 21;23(7):759-61
references.pmid: 211364
references.citation: J Pharmacol Exp Ther. 2008 Mar;324(3):1073-83
references.pmid: 18089845
references.citation: J Biol Chem. 2003 Sep 5;278(36):34631-40
references.pmid: 12815037
references.citation: Brain Res. 1996 Oct 21;737(1-2):175-87
references.pmid: 8930364
references.citation: Oncogene. 1998 Dec 24;17(25):3261-70
references.pmid: 9916988
references.citation: Neuroreport. 2008 Sep 17;19(14):1417-22
references.pmid: 18766023
references.citation: J Biol Chem. 1997 Feb 21;272(8):5040-7
references.pmid: 9030567
references.citation: Trends Pharmacol Sci. 2001 Jul;22(7):368-76
references.pmid: 11431032
references.citation: J Biol Chem. 1999 Aug 20;274(34):23802-7
references.pmid: 10446141
references.citation: J Biol Chem. 1984 Jan 25;259(2):1086-90
references.pmid: 6319376
references.citation: J Neurosci. 2004 Jul 28;24(30):6686-92
references.pmid: 15282271
references.citation: Neuropsychopharmacology. 2008 Feb;33(3):643-52
references.pmid: 17473837
references.citation: Cell Signal. 2009 Feb;21(2):179-85
references.pmid: 18790047
references.citation: Bioorg Med Chem Lett. 2009 Sep 15;19(18):5490-5
references.pmid: 19679471
references.citation: Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):23-47
references.pmid: 9716928
references.citation: J Biol Chem. 2005 Jul 29;280(30):27662-9
references.pmid: 15944153
references.citation: Life Sci. 2007 Mar 20;80(15):1439-48
references.pmid: 17316701
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11934-9
references.pmid: 12192085
references.citation: J Neurosci. 1997 Sep 1;17(17):6565-74
references.pmid: 9254669
references.citation: J Neurosci. 2005 Jan 5;25(1):29-41
references.pmid: 15634764
references.citation: J Biol Chem. 2006 Apr 21;281(16):10856-64
references.pmid: 16492667
references.citation: J Biol Chem. 2009 Jan 2;284(1):685-695
references.pmid: 19001375
references.citation: J Pharmacol Exp Ther. 2007 Jan;320(1):1-13
references.pmid: 16803859
references.citation: Biochemistry. 2009 Jul 28;48(29):6898-908
references.pmid: 19555087
references.citation: J Pharmacol Exp Ther. 1992 Mar;260(3):1237-43
references.pmid: 1312164
references.citation: Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9
references.pmid: 15464069
references.citation: Cell Calcium. 1999 Nov;26(5):219-26
references.pmid: 10643560
references.citation: J Neurochem. 1997 Dec;69(6):2405-12
references.pmid: 9375672
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19168-73
references.pmid: 19864633
references.citation: Pharmacol Rev. 1996 Dec;48(4):567-92
references.pmid: 8981566
references.citation: Biochim Biophys Acta. 1997 Oct 24;1333(2):F85-104
references.pmid: 9395283
references.citation: Biochem Pharmacol. 1997 Oct 1;54(7):809-18
references.pmid: 9353135
references.citation: J Biol Chem. 1998 Sep 18;273(38):24328-33
references.pmid: 9733719
references.citation: J Physiol. 1926 Aug 6;61(4):530-46
references.pmid: 16993813
references.citation: J Biol Chem. 2005 Apr 22;280(16):15649-58
references.pmid: 15728187
references.citation: J Biol Chem. 2009 Nov 13;284(46):31872-81
references.pmid: 19773548
references.citation: J Biol Chem. 2006 Nov 3;281(44):33749-60
references.pmid: 16954126
references.citation: PLoS Biol. 2005 Dec;3(12):e387
references.pmid: 16274263
references.citation: Trends Neurosci. 2005 Aug;28(8):436-45
references.pmid: 15982754
references.citation: Oncogene. 2007 May 14;26(22):3100-12
references.pmid: 17496909
references.citation: Science. 1982 Jan 22;215(4531):413-5
references.pmid: 6120570
references.citation: J Neurochem. 2008 Dec;107(6):1753-65
references.pmid: 19014370
references.citation: PLoS One. 2009 Dec 31;4(12):e8528
references.pmid: 20052275
references.citation: J Neurosci. 2003 Jul 2;23(13):5674-83
references.pmid: 12843270
references.citation: J Neurochem. 1998 Feb;70(2):635-45
references.pmid: 9453557
references.citation: Brain Res. 2010 Feb 16;1314:56-73
references.pmid: 19782055
references.citation: Biochem Biophys Res Commun. 1998 Feb 4;243(1):41-6
references.pmid: 9473476
references.citation: J Pharmacol Exp Ther. 1994 Sep;270(3):1381-6
references.pmid: 7932192
references.citation: Life Sci. 2004 Jun 18;75(5):511-36
references.pmid: 15158363
references.citation: J Biol Chem. 2001 Jun 22;276(25):23155-60
references.pmid: 11290747
references.citation: Neuron. 2003 Jul 3;39(1):9-12
references.pmid: 12848928
references.citation: Psychopharmacology (Berl). 2002 Oct;163(3-4):412-9
references.pmid: 12373442
references.citation: Nat Rev Neurosci. 2001 Oct;2(10):727-33
references.pmid: 11584310
references.citation: Pharmacol Rev. 1999 Sep;51(3):503-32
references.pmid: 10471416
references.citation: Science. 1993 Jul 9;261(5118):218-21
references.pmid: 8327893
references.citation: Science. 1986 Aug 15;233(4765):774-6
references.pmid: 3016896